Clinical Trial

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

Completed Phase 2
View on ClinicalTrials.gov →
Summary
A multicenter, randomized, double-blind, vehicle controlled phase II clinical study
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-18; most recent amendment 2026-04-10.
Status change: Recruiting → Completed 2026-04-10
Status change: Not Yet Recruiting → Recruiting 2025-05-05
Trial Details
NCT Number NCT06891040
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Atopic Dermatitis
Enrollment 118 participants
Start Date 2025-04-28
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-11-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-13